These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37790821)

  • 1. Let's Focus on the Fibrosis in Dupuytren Disease: Cell Communication Network Factor 2 as a Novel Target.
    Lambi AG; Morrell NT; Popoff SN; Benhaim P; Barbe MF
    J Hand Surg Glob Online; 2023 Sep; 5(5):682-688. PubMed ID: 37790821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupuytren Contractures: An Update of Recent Literature.
    Boe C; Blazar P; Iannuzzi N
    J Hand Surg Am; 2021 Oct; 46(10):896-906. PubMed ID: 34452797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies.
    Lambi AG; Popoff SN; Benhaim P; Barbe MF
    J Hand Surg Am; 2023 Aug; 48(8):810-821. PubMed ID: 36935324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and Direct Costs of Needle Aponeurotomy, Collagenase Injection, and Fasciectomy in the Treatment of Dupuytren Contracture.
    Leafblad ND; Wagner E; Wanderman NR; Anderson GR; Visscher SL; Maradit Kremers H; Larson DR; Rizzo M
    J Hand Surg Am; 2019 Nov; 44(11):919-927. PubMed ID: 31537401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.
    Yoon AP; Kane RL; Hutton DW; Chung KC
    JAMA Netw Open; 2020 Oct; 3(10):e2019861. PubMed ID: 33030553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DupuytrEn Treatment EffeCtiveness Trial (DETECT): a protocol for prospective, randomised, controlled, outcome assessor-blinded, three-armed parallel 1:1:1, multicentre trial comparing the effectiveness and cost of collagenase clostridium histolyticum, percutaneous needle fasciotomy and limited fasciectomy as short-term and long-term treatment strategies in Dupuytren's contracture.
    Räisänen MP; Karjalainen T; Göransson H; Reito A; Kautiainen H; Malmivaara A; Leppänen OV
    BMJ Open; 2018 Mar; 8(3):e019054. PubMed ID: 29599391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupuytren Disease Management Trends: A Survey of Hand Surgeons.
    Carr L; Michelotti B; Brgoch M; Hauck R; Ingraham J
    Hand (N Y); 2020 Jan; 15(1):97-102. PubMed ID: 30043624
    [No Abstract]   [Full Text] [Related]  

  • 8. Needle Aponeurotomy for Dupuytren Disease.
    Elzinga KE; Morhart MJ
    Hand Clin; 2018 Aug; 34(3):331-344. PubMed ID: 30012293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finger Joint Contractures 5 Years After Treatment for Dupuytren Disease: A Comparative Cohort Study of Collagenase Injection Versus Surgical Fasciectomy.
    Eckerdal D; Lauritzson A; Nordenskjöld J; Åkesson A; Atroshi I
    J Hand Surg Am; 2022 Sep; 47(9):834-842. PubMed ID: 35868901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.
    Chen NC; Shauver MJ; Chung KC
    J Hand Surg Am; 2011 Nov; 36(11):1826-1834.e32. PubMed ID: 21981831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future Needs.
    Degreef I
    Rheumatol Ther; 2016 Jun; 3(1):43-51. PubMed ID: 27747514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Management of Dupuytren Disease: A Systematic Review and Network Meta-analyses.
    Nann S; Kovoor J; Fowler J; Kieu J; Gupta A; Hewitt J; Ovenden C; Edwards S; Bacchi S; Jacobsen JHW; Harries R; Maddern G
    Hand (N Y); 2023 May; ():15589447231174175. PubMed ID: 37246411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase Treatment Versus Needle Fasciotomy for Single-Digit Dupuytren Contractures: A Meta-Analysis of Randomized Controlled Trials.
    Zhang D; Earp BE; Blazar P
    J Hand Surg Am; 2023 Dec; 48(12):1200-1209. PubMed ID: 37725027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Concepts in the Management of Dupuytren Disease of the Hand.
    Gil JA; Akelman MR; Hresko AM; Akelman E
    J Am Acad Orthop Surg; 2021 Jun; 29(11):462-469. PubMed ID: 33651754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupuytren Disease: Surgical Tips, Optimizing Outcomes, and Cost Considerations.
    Wagner ER; Gottschalk MB; Karzon AL; Graf AR; O'Shaughnessy MA; Suh N
    Instr Course Lect; 2023; 72():567-576. PubMed ID: 36534880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Needle Aponeurotomy for Stage IV Dupuytren Contracture: A Wide-Awake First Step Approach in 204 Consecutive Rays.
    Denkler KA; Park KM
    Plast Reconstr Surg; 2022 Nov; 150(5):1033e-1036e. PubMed ID: 35998126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupuytren's Contracture: An Evidence Based Review.
    Mella JR; Guo L; Hung V
    Ann Plast Surg; 2018 Dec; 81(6S Suppl 1):S97-S101. PubMed ID: 30161050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.
    Wong CR; Huynh MNQ; Fageeh R; McRae MC
    Hand (N Y); 2022 Nov; 17(6):1104-1113. PubMed ID: 33618538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive partial fasciectomy for Dupuytren contractures.
    Gelman SE; Schlenker R; Jacoby SM; Shin EK; Culp RW
    Tech Hand Up Extrem Surg; 2012 Dec; 16(4):184-6. PubMed ID: 23160547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.